Economic Evaluation of Palivizumab in Children With Congenital Heart Disease: A Canadian Perspective

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

Timothy F. Feltes, Allison K. Cabalka, H. Cody Meissner et al. · The Journal of Pediatrics · 2003 · 827 citations

Medicine, Cardiology, Pediatrics +17

National Institute for Clinical Excellence and its value judgments

M. D. Rawlins, Anthony J. Culyer · BMJ · 2004 · 769 citations · Full text

Public Affairs, Health Policy, Health Services Administration +17

Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children

Jessie R. Groothuis, Eric A. F. Simões, Myron J. Levin et al. · New England Journal of Medicine · 1993 · 747 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Respiratory syncytial virus infection

Eric A. F. Simões · The Lancet · 1999 · 614 citations

Life Sciences, Infectious Diseases, Microbiology +12

Respiratory Syncytial Viral Infection in Infants with Congenital Heart Disease

Noni E. MacDonald, Caroline Breese Hall, Stephen C. Suffin et al. · New England Journal of Medicine · 1982 · 611 citations

Medicine, Infectious Diseases, Pediatrics +17